Business Standard

Kilitch Drugs (India) standalone net profit rises 16.23% in the March 2019 quarter

Image

Capital Market

Sales rise 42.68% to Rs 22.40 crore

Net profit of Kilitch Drugs (India) rose 16.23% to Rs 2.65 crore in the quarter ended March 2019 as against Rs 2.28 crore during the previous quarter ended March 2018. Sales rose 42.68% to Rs 22.40 crore in the quarter ended March 2019 as against Rs 15.70 crore during the previous quarter ended March 2018.

For the full year,net profit rose 138.23% to Rs 14.77 crore in the year ended March 2019 as against Rs 6.20 crore during the previous year ended March 2018. Sales rose 91.08% to Rs 96.42 crore in the year ended March 2019 as against Rs 50.46 crore during the previous year ended March 2018.

 
ParticularsQuarter EndedYear EndedMar. 2019Mar. 2018% Var.Mar. 2019Mar. 2018% Var.Sales22.4015.70 43 96.4250.46 91 OPM %19.2415.29 -17.2111.04 - PBDT3.873.36 15 20.738.35 148 PBT3.533.05 16 19.537.16 173 NP2.652.28 16 14.776.20 138

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jun 01 2019 | 6:03 PM IST

Explore News